summary: Calprotectin has been considered as a marker of inflammation in a number of inflammatory diseases. Therefore, the authors aimed to investigate the role of calprotectin as a possible marker of inflammation in MS. They found that the levels of this molecule in the CSF were associated with the presence of clinical activity, reinforcing the possibility of its future use as a marker of inflammation in MS.

authors: Berg-Hansen P, Vandvik B, Fagerhol M, Holmøy T

source: J Neuroimmunol. 2009 Oct 1

weblink: click here

category: Immunology

related research news: click here

glossary: